Age-standardized prevalence of obesity among adults (18+ years)
SGLT2 inhibitors have been confirmed in clinical studies to improve biochemical indicators related to CKD-MBD, and their cardioprotective and nephroprotective effects are clear (114, 116)
Complimentary InBody Scans for Continued Progress 3-, 6-, and 12-month check-ins: FREE for all previous weight loss patients Available at our Fayetteville clinic quick, easy, and helps you stay accountable Track fat loss, muscle gain, hydration, and more at no additional cost GLP-1 Microdosing Program $300 Experience the metabolic and cardiovascular benefits of GLP-1 therapy beyond weight loss
Medications Are Most Used by Women Aged 50 to 64 For Release Wednesday August 6, 2025 Nearly 12 percent of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to a new RAND report